88
/ 100
True
The text questions if the Moderna vaccine will prevent melanoma from returning.
Infact verdict: True (88/100).
The claim that the Moderna vaccine will keep melanoma from returning is supported by evidence from multiple sources. An experimental mRNA cancer vaccine developed by Moderna and Merck has shown success in preventing melanoma recurrence in high-risk patients, reducing the risk by 49% when combined with Keytruda. This information is corroborated by sources such as KARK, Yahoo Health, and the Wall Street Journal, which report on the trial results. However, it is important to note that this is based on trial data and may not yet be widely applicable outside of controlled settings.
How is this score determined? →Individual claims
88
True
Health
The Moderna vaccine will keep melanoma from returning.
The claim is supported by trial results indicating that an experimental mRNA vaccine from Moderna and Merck reduces melanoma recurrence by 49% in high-risk patients. This is corroborated by multiple sources, including KARK, Yahoo Health, and the Wall Street Journal.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
85
Web Consensus Weight
40
Source Quality Score
80
Source Quality Weight
20
Llm Reasoning Score
70
Llm Reasoning Weight
40
Llm Reasoning Score Raw
70
Weighted Total
88
Evidence Summary
3 web sources corroborate the claim.
